Best Grants for Rare Diseases in Virgin Islands

Faculty researchers in biomedical, behavioral, or clinical sciences working on cardiovascular, respiratory, hematologic diseases or sleep disorders in the Virgin Islands can pursue mentored career development support through the National Institutes of Health. Focused on diversifying the investigator pool, this K01 award offers up to US $130,000 for supervised research leading toward independence.

Institutions that serve health disparity populations in the Virgin Islands or elsewhere can apply for NIH’s T32 Training Program to support research training in cardiovascular, pulmonary, hematologic, and sleep disorders. Eligible predoctoral, health professional, and postdoctoral training programs may benefit, including those working with rare respiratory disease populations.

Postdoctoral fellows in the NHLBI Division of Intramural Research conducting clinical trial-based biomedical research can apply for NIH’s K22 Career Transition Award, supporting a mentored intramural phase and a subsequent extramural phase. Grants from US Dept. of Health & Human Services: National Institutes of Health (NIH) may benefit investigators whose work involves respiratory or related rare diseases in the Virgin Islands and other eligible locations.

Medical schools, teaching hospitals, and similar institutions in the Virgin Islands can seek funding to provide mentored research education experiences in otolaryngology and related biomedical, behavioral, and clinical sciences. The National Institutes of Health offers this R25 program, with awards up to Up to US $2,499,995, which may benefit rare and respiratory disease-focused training programs.

Research institutions and investigators conducting basic or early translational nonmalignant hematology studies can apply for NIH R01 funding, including projects based in the Virgin Islands. US Dept. of Health & Human Services: National Institutes of Health supports work on blood and related systems that may intersect with rare respiratory or systemic diseases.

Small business concerns developing heart, lung, blood, or sleep disorder technologies for rare diseases or young pediatric populations in the Virgin Islands can access funding through the National Institutes of Health. Grants from NIH help advance Phase IIB SBIR projects toward regulatory approval and commercialization, with awards up to US $3,500,000 for later-stage research and development.

Small business concerns developing heart, lung, blood, or sleep-related technologies that need federal regulatory approval can seek later-stage SBIR Phase IIB funding, including in the Virgin Islands. Grants from US Dept. of Health & Human Services: National Institutes of Health help bridge the gap from prior SBIR/STTR Phase II awards to commercialization, with up to US $3,500,000 available.

Doctoral students conducting physical therapy or respiratory-related research at accredited institutions, including those in the Virgin Islands, can receive up to US $7,500 to support their coursework phase. Grants from the Foundation for Physical Therapy Research prioritize areas like cardiology, pulmonary care, PT education, and pelvic health for future academic researchers and educators.

Institutions training researchers in cardiovascular, pulmonary, hematologic, and sleep disorders can access funding through this NIH T32 program, including those in the Virgin Islands. Grants from the National Institutes of Health support predoctoral and postdoctoral training at institutions that serve health disparity populations and promote diversity in these research fields, which may include rare respiratory diseases.

Research institutions and similar organizations developing early-stage medical devices, diagnostic assays, or research tools for heart, lung, blood, and sleep conditions in the Virgin Islands can apply for National Institutes of Health support. NIH provides up to US $4,466,000 through phased R61/R33 awards for prototype design, testing, and related translational work.

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) aims to enhance research capabilities in eligible states by increasing the number of university researchers and institutions conducting relevant science and engineering research. Sponsored by the Department of Defense, this program will fund multiyear awards to promote research aligned with national security needs. Applications require a multi-stage submission process, emphasizing early registration and timely proposal submissions.

The US Flu Vaccine Effectiveness (VE) Network aims to enhance the effectiveness of vaccines against influenza and other respiratory pathogens, which are significant contributors to morbidity and mortality. This funding opportunity invites proposals for surveillance studies, including annual VE assessments, acute respiratory illness tracking, household transmission research, and immunogenicity studies. Applicants can apply for either Component A or B, with the option to include additional components based on their primary selection.

Grants from the National Institutes of Health help Virgin Islands respiratory and asthma research programs conduct multi-center, translational studies on asthma and allergic diseases. Eligible research teams may investigate disease mechanisms, progression, and treatment responses, including small clinical trials or observational studies, which can include work on rare or complex respiratory conditions.

Research institutions and clinical networks studying pediatric asthma prevention and treatment can apply for U.S. Dept. of Health & Human Services: National Institutes of Health support, including work in the Virgin Islands. Grants from NIH help respiratory disease researchers conduct multi-site clinical studies, test new treatment targets, and use systems biology to identify asthma endotypes in disadvantaged urban children.

Nonprofit research institutions and public universities in the Virgin Islands and other U.S. territories can seek funding for pediatric health and nutrition research benefiting infants and young children. Gerber Foundation supports projects developing practical diagnostic tools, treatments, and preventive measures; novice investigators may receive up to US $30,000 for mentored, early-career studies.

U.S.-based 501(c)(3) organizations and public institutions conducting pediatric environmental health research can apply for Gerber Foundation support, with awards up to US $350,000. With a mission to enhance the quality of life of infants and young children, the foundation funds applied studies on environmental hazards and nutrient competitors, which may benefit rare disease research in the Virgin Islands.

Graduate students and other qualified investigators conducting respiratory care education or credentialing research, including work on respiratory diseases and systems, can apply for up to US $5,000 in support from the American Respiratory Care Foundation. With a mission to promote respiratory health, this U.S. grant may benefit Virgin Islands projects studying rare or complex respiratory conditions.

Nonprofit organizations conducting respiratory care research in the Virgin Islands can seek support for projects involving respiratory therapists or technicians in a meaningful way. The American Respiratory Care Foundation’s Parker B. Francis Respiratory Research Grant provides up to US $10,000 to supplement other funding for studies on respiratory diseases and related topics.

Nonprofit organizations conducting respiratory care research, including applied clinical or basic studies in cardiopulmonary medicine, can seek funding for projects involving respiratory therapists or technicians. The American Respiratory Care Foundation supports these efforts through the Jerome M. Sullivan Research Fund, offering up to US $10,000, which may benefit Virgin Islands projects on respiratory and related rare diseases.

Early-career respiratory care researchers focusing on pediatric respiratory therapy can receive up to US $5,000 to support their first research projects and professional development. The Smallwood Young Investigator Fellowship, offered by the American Respiratory Care Foundation, may benefit investigators in the Virgin Islands working on respiratory diseases and related rare conditions.

Health care professionals from outside the U.S. seeking advanced training in respiratory care can access an International Fellowship that covers U.S. lodging, food allowance, local transportation, and AARC Congress registration. Grants from American Respiratory Care Foundation help Virgin Islands respiratory and rare disease clinicians observe U.S. hospital, education, and alternate care practices over a structured multi-city visit.

The PFF Research Fund to Cure Pulmonary Fibrosis aims to support innovative research that enhances understanding and treatment of pulmonary fibrosis. The PFF Scholars Program provides $100,000 over two years to early-stage researchers, encouraging them to pursue independent funding opportunities. Eligible applicants include post-doctoral trainees and early Assistant Professors committed to interstitial lung disease research. This initiative fosters mentorship and collaboration, ultimately advancing the field and improving patient care.

The Heiser Program for Research in Leprosy, established by Dr. Victor G. Heiser, focuses on innovative biomedical research to combat leprosy. Since 1975, it has funded over 200 grants totaling more than $20 million, supporting early-career researchers and significant projects. The program aims to enhance diagnostic tools, improve treatments, and implement effective surveillance strategies. With a dedicated Scientific Advisory Committee, it ensures rigorous proposal reviews and fosters collaboration among grantees, ultimately advancing leprosy elimination efforts.

The FSR Early Career Fellowship Grant supports early-stage researchers in sarcoidosis, fostering skills and knowledge advancement. With $150,000 over two years, this grant aims to enhance medical care and scientific understanding of the disease. Eligible applicants, including international candidates, must present innovative study proposals and demonstrate a commitment to sarcoidosis research. FSR encourages transitions from fellowships to faculty positions, thereby strengthening academic credentials and promoting impactful research contributions.

The Emerging Global Leader Award (K43) offers essential research support and protected time for early career scientists in low- and middle-income countries. This program, aligned with NIH's clinical trials policy, aims to cultivate independent research careers by providing mentorship and funding over three to five years. Eligible candidates must hold a junior faculty position at an accredited LMIC institution, fostering the growth of research capacity in their regions.

The Fogarty Emerging Global Leader Award supports early career research scientists from low- or middle-income countries (LMIC) by providing research funding and mentored career development for three to five years. This program encourages LMIC scientists in health-related fields to develop projects aligned with their country's health priorities, fostering independent research careers within their institutions. Applications are welcomed from junior faculty members, enhancing global health research and capacity in LMICs.

The Patient-Centered Outcomes Research Institute (PCORI) intends to release an Implementation of Findings From PCORI's Research Investments PCORI Funding Announcement (PFA) on Aug. 4, 2026, seeking to fund implementation projects that promote the uptake of peer-reviewed findings from specific PCORI-funded patient-centered comparative clinical effectiveness research (CER) in the context of the body of related evidence. This PFA is an open competition opportunity for principal investigators to propose implementation projects that move evidence toward practical use in improving health care and health outcomes. Applicants may propose projects with budgets up to $1.8 million in total direct costs.

PCORI seeks to fund implementation projects that incorporate active, multicomponent strategies that will lead to uptake and integration of evidence generated by PCORI-funded research in practice settings. Implementation should target specific end users with a clear interest in — and ability to benefit from — the evidence. Proposed implementation projects will adapt findings as needed to facilitate uptake in the proposed settings and accomplish scale-up to reach larger numbers and/or scale-out to reach broader populations and settings. Applicants must demonstrate commitment and buy-in — including from leadership as well as frontline staff critical to the success of the project — from proposed implementation sites across multiple health systems, such that they provide a supportive context and infrastructure for undertaking the proposed project. In addition, projects should involve regional and national stakeholder organizations positioned to extend uptake in broader venues.  

Applications must be guided by an established conceptual model or framework and, where possible, by evidence regarding effective strategies for implementing evidence-based practices and interventions. Additionally, applications must include a rigorous evaluation plan that documents the successful execution of the implementation approach and the impact of the project on health care and health outcomes as feasible and appropriate within the project scope.